David L Enfield

Title: Innovations in Cancer Screening by David L. Enfield

Introduction

David L. Enfield is a notable inventor based in Bothell, WA (US), recognized for his contributions to cancer screening technologies. With a total of 2 patents, Enfield has made significant strides in the field of medical diagnostics, particularly in relation to colorectal cancers.

Latest Patents

Enfield's latest patents focus on innovative methods for screening and treating cancers. One patent details methods of screening for colorectal cancers, emphasizing the role of complement Factor I or related proteins. This invention outlines screening methods based on the detection of complement C3 or related proteins, which are associated with the presence of cancer. Additionally, it includes methods utilizing complement regulators and receptors, with preferred embodiments involving various detection techniques such as immunological and enzymatic properties. Another patent describes methods for screening or modulating tumors, highlighting the detection of antigens or nucleic acid molecules associated with cancer. These methods also incorporate advanced detection techniques based on immunological and physical properties.

Career Highlights

David L. Enfield is currently associated with Bard Diagnostic Sciences, Inc., where he continues to develop and refine his innovative approaches to cancer diagnostics. His work has the potential to significantly impact early detection and treatment strategies for cancer patients.

Collaborations

Enfield has collaborated with esteemed colleagues, including Robert J. Kinders and G. Michael Hass, contributing to a dynamic research environment focused on advancing cancer screening technologies.

Conclusion

David L. Enfield's innovative work in cancer screening exemplifies the critical role of inventors in advancing medical technology. His patents reflect a commitment to improving diagnostic methods, ultimately benefiting patient care and outcomes.